LI HUI-YIN,RODGERS JAMES D.,LI Hui-Yin,RODGERS James D.
申请号：
SI200831217
公开号：
SI2173752T1
申请日:
2008.06.12
申请国别(地区):
SI
年份:
2014
代理人:
摘要：
The present invention provides salt forms of (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1 H-pyrazol-1-yl)-3-cyclopentylpropanenitrile that are useful in the modulation of Janus kinase activity and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.
